Clinical Trials

VGI Health Technology Limited (NSX:VTL) Appointment of Professor Crawford to SAB

🕔9/15/2021 10:12:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that eminent hepatologist, Professor Darrell H.G. Crawford, has been appointed to its Scientific Advisory Board (SAB).

Read Full Article

VGI Health Technology Limited (NSX:VTL) Appointment of Clinical Study Site

🕔9/14/2021 9:56:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has appointed Gallipoli Medical Research Foundation (GMRF) as a clinical study site for Phase II Clinical Study.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Study Protocol Approved

🕔9/13/2021 9:39:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it's operational subsidiary, Invictus Ops Pty Ltd., has approved a clinical study protocol for a clinical study to be conducted by Altipure R&D in Ohio.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Renewal of Research and Development Receivable Facility

🕔9/7/2021 9:12:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has agreed with FIFO Capital to renew a Receivable Finance Facility with respect to VTL's assessed tax cash benefit under the Federal Government's R&D Tax Incentive Program.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Certification of NE1-Elite(R)

🕔8/12/2021 9:30:00 AM

Invictus Nutraceuticals, Inc. (Florida, USA), a wholly owned subsidiary of VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has partnered with Informed Sport to certify its NE1-Elite(R) product.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Shareholder Update

🕔7/13/2021 1:09:00 PM

VGI Health Technology Limited (NSX:VTL) recently signed a manufacturing and supply agreement with a US manufacturer, Altipure LLC, for finished nutraceutical products for sale and clinical study drugs for our clinical studies.

Read Full Article

Azure Health Technology Limited (NSX:VTL) Receipt of Finished Nutraceutical Products

🕔6/15/2021 9:49:00 AM

Further to Azure Health Technology Limited's (NSX:VTL) announcement on 16 March 2021 that the first manufacturing run for our finished nutraceutical products has been completed.

Read Full Article